Democratizing hedge fund level analysis tools for everyone
| Name | Pyridam Farma Tbk |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| Rejuve Global Investment PT. Ltd | 60.46 | 60.46 |
| Public < 5% | 34.45 | 34.45 |
| PT. Asuransi Jiwa Starinvestama | 5.1 | 5.1 |
| Source | 2022 | 2021 |
|---|---|---|
| PYFA | F2 | Pharmaceutical Products, Esthetic and Toll Products and Toll Manufacturing Services |
| PYFA | F2 | Medical Equipment |
| PYFA | F2 | Others |
| PYFA | F2 | Derma Products |
| Region | 2022 | 2021 |
|---|---|---|
| PYFA | F2 | Indonesia |
| PYFA | F2 | Others |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 2.13 | # 13 / 15 |
| EV_EBITDA | -434.03 | --- / 15 |
| PER | -13.79 | --- / 15 |
| PBV | 7.87 | # 14 / 15 |
| DER | 7.00 | # 14 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | -15.389 | --- / 15 |
| ROA % | -6.22 | --- / 15 |
| ROE % | -56.87 | --- / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2019 | 1.72 | 0.8 |
| Timeframe | Performance |
|---|---|
| 1W % | -5.4 |
| 1Mo % | -3.7 |
| 3Mo % | 69.4 |
| 1Yr % | 240.9 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 15.76 | 62.26 T | 63.77 T | 34,159 B | 5,862 B | 3,950 B |
| SOHO | 44.61 | 25.89 T | 28.01 T | 10,338 B | 711 B | 581 B |
| SIDO | 14.24 | 17.10 T | 16.78 T | 3,657 B | 1,604 B | 1,201 B |
| TSPC | 8.97 | 12.63 T | 11.54 T | 13,197 B | 1,807 B | 1,404 B |
| PYFA | -13.79 | 5.90 T | 11.63 T | 2,771 B | -27 B | -426 B |
| KAEF | -8.56 | 3.48 T | 14.83 T | 8,673 B | 365 B | -409 B |